Author: Piedade, Juliana; Pereira, Gustavo
Title: COVID-19 in Liver Transplant Recipients Cord-id: qw9muefc Document date: 2021_7_22
ID: qw9muefc
Snippet: Coronavirus disease 2019 (COVID-19), an infection caused by severe acute respiratory syndrome coronavirus-type 2 (SARS-CoV-2), has emerged as a serious threat to public health. Liver transplant (LT) recipients may be at increased risk of acquisition of SARS-CoV-2 infection and higher morbidity and mortality due to constant contact with health-care services, the use of immunosuppressants and frequent comorbidities. In the first part of this review we discuss 1) the epidemiology and risk factors f
Document: Coronavirus disease 2019 (COVID-19), an infection caused by severe acute respiratory syndrome coronavirus-type 2 (SARS-CoV-2), has emerged as a serious threat to public health. Liver transplant (LT) recipients may be at increased risk of acquisition of SARS-CoV-2 infection and higher morbidity and mortality due to constant contact with health-care services, the use of immunosuppressants and frequent comorbidities. In the first part of this review we discuss 1) the epidemiology and risk factors for SARS-CoV-2 infection in LT recipients; 2) the clinical and laboratory features of COVID-19 in this specific population, highlighting differences in presenting signs and symptoms with respect to general populations and 3) the natural history and prognostic factors in LT recipients hospitalized with COVID-19, with particular focus on the possible role of immunosuppression. Thereafter, we review the potential therapeutic options for COVID-19 treatment and prevention. Specifically, we give an overview of current practice in immunosuppressant regimen changes, showing the potential benefits of this strategy, and explore safety and efficacy issues of currently approved drugs in LT recipients. The last topic is dedicated to the potential benefits and pitfalls of vaccination.
Search related documents:
Co phrase search for related documents- abdominal pain and acute liver injury: 1, 2, 3, 4, 5
- abdominal pain and acute respiratory distress syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16
- abdominal pain and adequate protection: 1
- abdominal pain and liver disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- abdominal pain and liver donor: 1, 2
- abdominal pain and liver enzyme: 1, 2, 3, 4, 5, 6, 7, 8
- abdominal pain and liver function: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21
- acquire risk and liver function: 1
- active previous and acute respiratory distress syndrome: 1, 2
- active previous and liver disease: 1
- active previous cancer and acute respiratory distress syndrome: 1
- acute kidney injury and adequate protection: 1
- acute kidney injury and liver disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- acute kidney injury and liver enzyme: 1, 2, 3
- acute kidney injury and liver function: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
- acute liver injury and liver disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- acute liver injury and liver enzyme: 1, 2, 3
- acute liver injury and liver function: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18
- acute rejection and liver function: 1, 2, 3, 4, 5
Co phrase search for related documents, hyperlinks ordered by date